Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
194 Leser
Artikel bewerten:
(0)

Protege Biomedical, LLC: Protégé Biomedical Launches New Sampling Program for Veterinary Practices

MINNEAPOLIS, MN / ACCESSWIRE / July 10, 2018 / Protégé Biomedical, the makers of ClotIt® and ClotIt VETTM, is a medical device company that offers a proven line of hemostatic blood-stopping products to the veterinary professional. Today, Protégé Biomedical is pleased to announce a new, free sampling program for veterinary clinics in the US.

The ClotIt VET Sampling Program is for veterinary practices. It offers veterinary clinics samples of our sterile and non-sterile products. The ClotIt VET Sample Kit includes one long-tip sterile application, one sample of non-sterile use, brochures, literature, case studies, and clinical studies of our product. Veterinary practices can request a sample online at www.clotitvet.com/pages/sample-request/.

"We are excited to launch this sampling program as it gets our 21st-century platform of sterile and non-sterile hemostasis products in the hands of veterinary professionals in all clinics, emergency facilities, and regular practices with a no-cost option to them," says Ron Shay, VP of Sales at Protégé Biomedical. "The goal of this sampling program is to get veterinary professionals to use ClotIt VET and see how it's superior science improves their results in any hemostatic surgical condition." After trial usage, ClotIt VET is available through any of the main-stream Veterinary Distributors listed below.

ClotIt VET's line of products is available through the following veterinary distributors: VEDCO Animal Health, Henry Schein Animal Health, Midwest Veterinary Supply, Miller Veterinary Supply, MWI Veterinary Supply, Patterson Veterinary, Penn Veterinary Supply, and First Veterinary Supply.

ClotIt VET features Protégé Biomedical's patented Ionic Hemostatic Mineral (IHM) Technology to stop bleeding and keep it stopped in wounds of all sizes for animals. ClotIt VET enhances an animals' own bodily functions to speed clotting and keep a clot firmly in place. With the launch of the ClotIt VET Sampling Program, veterinary clinicians can adopt a unique "Total Clinic Approach," and become totally prepared to meet the hemostatic demands of any day-to-day or emergency related hemostatic procedures.

For all inquiries about the ClotIt VET Sampling Program or Protégé Biomedical's line of hemostatic products, please contact Ron Shay at ron.shay@protegebiomedical.com or +1 (480) 227-7696. Please note that this sampling program is a limited time offer and will continue while supplies last.

About the Company

Protégé Biomedical is a medical device company with a unique and patented line of hemostatic products developed to stop bleeding fast and keep it stopped, in animals and, pending FDA clearance, humans. Protégé Biomedical's hemostatic platform uses a patented compound of all-natural minerals designed to work with the body's own bodily functions to accelerate natural clotting, and quickly establish faster, harder clots.

SOURCE: Protégé Biomedical, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.